ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,011Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 623

$645K Total Retail Price of All Prescriptions

Rank: 22 out of 623

563 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 9,016 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 473 401 1 2
LISINOPRIL 448 398 2 1
LEVOTHYROXINE SODIUM 340 304 3 4
HYDROCODONE-ACETAMINOPHEN 322 271 S3 4 17
FUROSEMIDE 278 233 5 5
METFORMIN HCL 275 210 6 6
OMEPRAZOLE 272 197 7 7
METOPROLOL TARTRATE 240 204 8 9
ATENOLOL 210 172 9 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 172 10 19
AMLODIPINE BESYLATE 192 178 11 3
ZOLPIDEM TARTRATE 173 134 12 22
ATORVASTATIN CALCIUM 165 140 13 10
HYDROCHLOROTHIAZIDE 164 151 14 8
OXYCODONE-ACETAMINOPHEN 162 131 S2 15 42
METOPROLOL SUCCINATE 157 135 16 13
WARFARIN SODIUM 143 140 17 14
PRAVASTATIN SODIUM 138 122 18 11
CRESTOR 123 119 19 28
CITALOPRAM HBR 122 97 20 21
LOSARTAN POTASSIUM 119 104 21 16
GLIMEPIRIDE 118 96 22 38
LOVASTATIN 99 95 23 25
PANTOPRAZOLE SODIUM 97 58 24 26
TRAMADOL HCL 96 77 25 15
CLOPIDOGREL 94 70 26 34
POTASSIUM CHLORIDE 88 75 27 24
AZITHROMYCIN 86 55 28 45
RANITIDINE HCL 86 58 28 23
TRAZODONE HCL 85 66 30 36
ADVAIR DISKUS 82 62 31 39
AMLODIPINE BESYLATE-BENAZEPRIL 77 60 32 92
PLAVIX 75 56 33 46
PREDNISONE 75 66 33 40
NEXIUM 75 66 33 43
ZETIA 73 57 36 99
PROMETHAZINE VC 68 60 R 37 184
PAROXETINE HCL 67 49 38 66
VYTORIN 67 54 38 171
GLYBURIDE 65 62 R 40 103
IPRATROPIUM BROMIDE 65 49 40 133
PROAIR HFA 64 50 42 57
SERTRALINE HCL 64 48 42 20
METHOCARBAMOL 63 39 R 44 172
TAMSULOSIN HCL 62 54 45 35
MELOXICAM 62 45 45 50
CARVEDILOL 58 48 47 32
SPIRIVA 58 44 47 58
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 49 59
RAMIPRIL 56 46 49 79
TRIAMTERENE-HCTZ 56 53 49 74
AMOXICILLIN 55 50 52 98
IBUPROFEN 55 50 52 68
SUCRALFATE 53 51 54 222
GABAPENTIN 52 34 55 18
GEMFIBROZIL 52 39 55 110
DONEPEZIL HCL 51 51 57 27
TRILIPIX 50 50 58 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.